Product Information
DAPTOMYCIN 500 MG VIAL is a generic product labeled by Civica, Inc., priced at $21.8463 per EA under NDC 72572010201. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
500 mg/10mL
Manufacturer
Civica, Inc.NDC
72572010201
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
DAPTOMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA206005On Market Since
8/20/2019
Pharmacological Classes
Price Statistics
The NADAC for DAPTOMYCIN 500 MG VIAL has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.8463 per EA |
|---|---|
| All-time high | $28.3900 (Sep 11, 2024) |
| All-time low | $20.1020 (Oct 22, 2025) |
| 52-week high | $24.2743 |
| 52-week low | $20.1020 |
| Median price | $22.1643 |
| Average price | $22.8446 |
| Largest weekly change | -17.2% (Oct 22, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DAPTOMYCIN 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DAPTOMYCIN 500 MG VIAL, manufactured by Civica, Inc., is $21.8463 per EA (NDC 72572010201), effective Jun 24, 2026.
How has the price of DAPTOMYCIN 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for DAPTOMYCIN 500 MG VIAL has declined 12.1%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DAPTOMYCIN 500 MG VIAL?
Since Apr 17, 2024, the NADAC for DAPTOMYCIN 500 MG VIAL has ranged from a low of $20.1020 (Oct 22, 2025) to a high of $28.3900 (Sep 11, 2024), with a median of $22.1643 per EA.
Are there cheaper alternatives to DAPTOMYCIN 500 MG VIAL?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DAPTOMYCIN 500 MG VIAL, is $20.7686 per EA — about 5% below DAPTOMYCIN 500 MG VIAL.
Who manufactures DAPTOMYCIN 500 MG VIAL?
DAPTOMYCIN 500 MG VIAL (NDC 72572010201) is labeled by Civica, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification